Annotation Detail for CDH10

Basic Information
Top
Pathway ID | Pathway Name |
---|
| Cell junction organization |
Pathway ID | Pathway Name |
---|
P00012 | Cadherin signaling pathway |
P00057 | Wnt signaling pathway |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of CDH10 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CDH10 mRNA | affects expression | 16483693
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of CDH10 mRNA | increases expression | 20106945
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of CDH10 mRNA | increases expression | 20106945
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of CDH10 mRNA | increases expression | 18035473
|
D014415 |
Tunicamycin |
Tunicamycin results in increased expression of CDH10 mRNA | increases expression | 17127020
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.02 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.04 | 20464547 20127859 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.82 | 6695378 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.49 | 19183758 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 19404256 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.00 | 17474063 20146248 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
1.98 | 21507988 12907637 12619106 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.12 | 20419170 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.73 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.14 | 19486331 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.07 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.18 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.56 | 12168785 12639820 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.68 | 8708960 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.80 | 20471113 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.88 | 15720958 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.19 | 10903974 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
2.79 | 17296493 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.96 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.50 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.00 | 12371664 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
4.89 | 18177683 15890375 2125692 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.89 | 20195826 21137059 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
2.92 | 8603461 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.49 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.49 | 20464547 18520028 18816296 20135361 18569708 17053015 20869020 6695378 20064080 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.31 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.43 | 16381670 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.30 | 11141357 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.96 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.57 | 18481113 19348381 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.51 | 12371664 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.92 | 17292933 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.31 | 16882103 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.49 | 19755658 10029692 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.28 | 17053015 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.50 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.96 | 17120751 |
Pathway ID |
Pathway Name |
---|
REACT:20676 |
Cell junction organization |
PharmGKB Accession:PA26283
Releated disease ID |
Related disease Name |
PA445218 | Pancreatic Neoplasms |
PA443560 | Breast Neoplasms |